Successor-in-Interest (Type 6 Parent Clinical Trial Optional)
This grant funds clinical trial research under the Successor-in-Interest program.
About this program
The Successor-in-Interest (Type 6 Parent Clinical Trial Optional) grant is designed to support clinical trial research initiatives. It provides funding for projects that aim to advance medical knowledge and improve patient outcomes through innovative clinical trials. This grant is particularly beneficial for organizations engaged in healthcare research and development, allowing them to explore new treatment options and methodologies. Eligible applicants include research institutions, healthcare organizations, and other entities involved in clinical trials. The grant aims to foster collaboration among various stakeholders in the healthcare sector, ensuring that the research conducted is relevant and impactful. By providing financial support, the grant enables organizations to focus on their research objectives without the burden of funding constraints.
Eligibility
Research institutions, healthcare organizations, and other entities involved in clinical trials.